Table 1.
|
Peripheral neuropathy |
||||
---|---|---|---|---|---|
Normal | Mild | Moderate | Severe | Total | |
Omega- 3 supplemented group |
21(70%) |
4(13.3%) |
5(16.7%) |
0% |
30(100%) |
Placebo received group | 11(40.7%) | 10(37%) | 5(18.5%) | 1(3.7%) | 27(100%) |
A significant difference in PN incidence (OR = 0.3, .95% CI = (0.10 - 0.88), p = 0.029).
No significant difference in severity of PN (B = −1.02, .95% CI = (−2.06 - 0.02), p = 0.054).